Elanco Animal Health Incorporated (ELAN) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$26.16
Price Target
$27.88
Target Range
$22.00 — $30.00
Analyst Rating
Buy
Forward P/E25.4x
Trailing P/E-55.7x
Forward PEG—
Implied Growth+320.7%
Median Target$29.50
Analyst Spread28.7%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$22
-15.9%
Consensus
$28
+6.6%
Bull Case
$30
+14.7%
ELAN Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Elanco Animal Health Incorporated (ELAN) has a Wall Street consensus price target of $27.88, based on estimates from 20 covering analysts. With the stock currently trading at $26.16, this represents a potential upside of +6.6%. The company has a market capitalization of $13.06B.
Analyst price targets range from a low of $22.00 to a high of $30.00, representing a 29% spread in expectations. The median target of $29.50 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ELAN trades at a trailing P/E of -55.7x and forward P/E of 25.4x. Analysts expect EPS to grow +320.7% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+24.2%
Avg Forward P/E18.5x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ZTSZoetis Inc. | $46.9B | $111.22 | $143.00 | +28.6% | Hold | 15.8x | 30 |
 PCRXPacira BioSciences, Inc. | $932M | $23.69 | $29.50 | +24.5% | Hold | 8.6x | 36 |
 PAHCPhibro Animal Health Corporation | $2.4B | $58.64 | $49.00 | -16.4% | Buy | 19.3x | 13 |
 NEOGNeogen Corporation | $2.0B | $9.18 | $11.00 | +19.8% | Hold | 25.7x | 11 |
 PETSPetMed Express, Inc. | $49M | $2.31 | — | — | — | — | — |
 CHWYChewy, Inc. | $10.2B | $24.59 | $41.71 | +69.6% | Buy | 28.1x | 38 |
 ANIPANI Pharmaceuticals, Inc. | $1.8B | $84.06 | $124.00 | +47.5% | Buy | 9.3x | 10 |
 LLYEli Lilly and Company | $932.6B | $987.11 | $1258.47 | +27.5% | Buy | 28.6x | 45 |
 PFEPfizer Inc. | $150.8B | $26.50 | $27.27 | +2.9% | Hold | 9.0x | 39 |
 MRKMerck & Co., Inc. | $280.5B | $113.56 | $129.31 | +13.9% | Buy | 22.2x | 37 |
Upside Potential Comparison
CHWYANIPZTSLLYPCRXNEOGMRKPFEFull ELAN Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ELAN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELAN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ELAN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonELAN — Frequently Asked Questions
Quick answers to the most common questions about buying ELAN stock.
What is the ELAN stock price target for 2026?
The consensus price target for ELAN is $27.88, close to the current price of $26.16 (6.6% implied move). Based on 20 analyst estimates, the stock appears fairly valued near current levels.
Is ELAN a buy, sell, or hold?
ELAN has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $27.88 implies 6.6% upside from current levels.
Is ELAN stock overvalued or undervalued?
ELAN trades at a forward P/E of 25.3857x, representing a moderate valuation. With analysts targeting $27.88 (6.6% implied move), the stock appears reasonably valued with upside.
How high can ELAN stock go?
The most bullish Wall Street analyst has a price target of $30 for ELAN, while the most conservative target is $22. The consensus of $27.88 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover ELAN stock?
ELAN is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ELAN stock forecast?
The 12-month ELAN stock forecast based on 20 Wall Street analysts shows a consensus price target of $27.88, with estimates ranging from $22 (bear case) to $30 (bull case). The median consensus rating is "Buy".
What is ELAN's forward P/E ratio?
ELAN trades at a forward P/E ratio of 25.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ELAN stock?
ELAN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $27.88 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ELAN price targets vary so much?
ELAN analyst price targets range from $22 to $30, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $27.88 consensus represents the middle ground.